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ABSTRACT Antibodies HyHEL8, HyHEL10, and HyHEL26 (HH8, HH10, and HH26, respectively) recognize highly overlap-
ping epitopes on hen egg-white lysozyme (HEL) with similar affinities, but with different specificities. HH8 binding to HEL is
least sensitive toward mutations in the epitope and thus is most cross-reactive, HH26 is most sensitive, whereas the
sensitivity of HH10 lies in between HH8 and HH26. Here we have investigated intra- and intermolecular interactions in three
antibody–protein complexes: theoretical models of HH8-HEL and HH26-HEL complexes, and the x-ray crystal structure of
HH10-HEL complex. Our results show that HH8-HEL has the lowest number and HH26-HEL has the highest number of intra-
and intermolecular hydrogen bonds. The number of salt bridges is lowest in HH8-HEL and highest in HH26-HEL. The binding
site salt bridges in HH8-HEL are not networked, and are weak, whereas, in HH26-HEL, an intramolecular salt-bridge triad at
the binding site is networked to an intermolecular triad to form a pentad. The pentad and each salt bridge of this pentad are
exceptionally stabilizing. The number of binding-site salt bridges and their strengths are intermediate in HH10-HEL, with an
intramolecular triad. Our further calculations show that the electrostatic component contributes the most to binding energy
of HH26-HEL, whereas the hydrophobic component contributes the most in the case of HH8-HEL. A “hot-spot” epitope
residue Lys-97 forms an intermolecular salt bridge in HH8-HEL, and participates in the intermolecular pentad in the
HH26-HEL complex. Mutant modeling and surface plasmon resonance (SPR) studies show that this hot-spot epitope residue
contributes significantly more to the binding than an adjacent epitope residue, Lys-96, which does not form a salt bridge in
any of the three HH-HEL complexes. Furthermore, the effect of mutating Lys-97 is most severe in HH26-HEL. Lys-96, being
a charged residue, also contributes the most in HH26-HEL among the three complexes. The SPR results on these mutants
also highlight that the apparent “electrostatic steering” on net on rates actually act at post-collision level stabilization of the
complex. The significance of this work is the observed variations in electrostatic interactions among the three complexes. Our
work demonstrates that higher electrostatics, both as a number of short-range electrostatic interactions and their contribu-
tions, leads to higher binding specificity. Strong salt bridges, their networking, and electrostatically driven binding, limit
flexibilities through geometric constrains. In contrast, hydrophobic driven binding and low levels of electrostatic interactions
are associated with conformational flexibility and cross-reactivity.
INTRODUCTION
Biomolecular association is proposed to occur in two steps:
1) encounter, which involves diffusion-limited orientation
of the two molecules driven by nonspecific, long-range,
electrostatic forces followed by collision to form a hydro-
phobically associated encounter complex; and 2) docking
with the formation of specific contacts and noncovalent
bonds (Haselkorn et al., 1974; Ross and Subramanian,
1981; Schreiber and Fersht, 1996). Electrostatic interactions
would therefore be expected to directly influence the initial
association, through steering, and the strength of docked
complex due to electrostatic interactions of salt bridges and
hydrogen bonds. Ligand binding also often induces confor-
mational changes in both receptor and ligand during the
docking step (Musci et al., 1988; Nicholson et al., 1995;
Wagner 1995; Sparrer et al., 1996; Kawaguchi et al., 1997;
Walters et al., 1997; Lindner et al., 1999).
Antibody–antigen complexes have long served as models
to study general principals of protein–protein interactions
and molecular recognition, both experimentally (Kabat et
al., 1977; Smith-Gill, 1991; Wilson and Stanfield, 1993;
Tsumoto et al., 1994; Braden and Poljak, 1995; Dall’Acqua
et al., 1998) and computationally (Novotny et al., 1989;
Chong et al., 1999; Freire, 1999). High-affinity antibodies,
very specific toward their antigens (Eaton et al., 1995), or
proposed to have “lock and key” type of binding (Wede-
mayer et al., 1997), have higher electrostatic interactions
with their antigens (Chong et al., 1999). In contrast, more
cross-reactive antibodies are believed to be more flexible
and involve less specific contacts. It is becoming increas-
ingly evident that flexibility may also play a major role in
specificity and dynamics of high-affinity antibodies (Mian
et al., 1991; Foote and Milstein 1994; Ditzel et al., 1996;
Sheriff et al., 1996; Diaw et al., 1997), even in cases where
crystal structures of the complexed and uncomplexed anti-
bodies did not indicate significant induced fit (Lindner et
al., 1999). Nevertheless, the functional role and the struc-
tural basis of conformational change in antibody binding
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FIGURE 1 Illustration of HH antibodies structural associations with HEL. Sequence alignment of (a) light-chains, and (b) heavy-chains of HH8, HH10,
and HH26 antibodies. Colored areas represent the complementarity determining regions (CDRs). Red depicts conserved residues and blue depicts
substitutions. Conserved and substituted residues are only shown for CDRs. There are no insertions and deletions, and CDRs are of identical lengths (Padlan
et al., 1989). The substitutions occur in CDRs and the frame work regions of the antibodies. Light chains of these antibodies are encoded from the same
Vk germ line gene, while their heavy chains belong to the same family (Lavoie et al., 1992). Two charged residues, which might be playing important roles
in the electrostatically driven binding, are somatically mutated to hydrophobic residues in HH8. The residue Lys-49L, in CDR 2 of the light chain and
residue Asp-101H, in CDR 3 of the heavy chain, present in HH10 and HH26, have been mutated to threonines in HH8. These residue differences have been
shown to play a role in determining the binding mechanisms of these antibodies, possibly through long range effects (Lavoie et al., 1992). Similarly, the
positions of two tyrosines, Tyr-53H and Tyr-58H, in CDR 2 of the heavy chain in HH10 and HH26, are occupied by phenylalanines in HH8. (c) HH10-HEL
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remains unpredictable for any given complex, and the struc-
tural and thermodynamic determinants of antibody specific-
ity and affinity are not completely understood.
We have previously proposed that differences in fine
specificity among three structurally and functionally related
antibody–protein complexes reflect their relative flexibili-
ties, which are modulated, at least in part, by intramolecular
salt links and salt-link networks within the complementar-
ity-determining regions (CDRs), and by the proportions of
hydrophobic and electrostatic residues (S. Mohan and S. J.
Smith-Gill, submitted). Monoclonal antibodies HyHEL8,
HyHEL10 and HyHEL26 (HH8, HH10 and HH26, respec-
tively), share more than 90% of sequence homology (Fig. 1,
a and b), and are specific for similar epitopes on hen egg
white lysozyme (HEL) (Newman et al., 1992; Y. Li, C. A.
Lipschultz, and S. J. Smith-Gill, unpublished results) (Fig.
1 c), with similar affinity (Lavoie et al., 1992, 1999). The
structural, functional, and physical properties of HH8,
HH10, and HH26 correlate with their cross-reactivity prop-
erties, ranking HH8 at one extreme, HH26 at the other, and
HH10 intermediate. Of particular interest to the present
study are the varying number of intramolecular salt bridges
at the binding sites, which rank HH8  HH10  HH26, and
the differences in the proportion of hydrophobic residues,
which rank HH8  HH10  HH26 (Smith-Gill et al., 1987;
S. Mohan and S. J. Smith-Gill, submitted). Salt bridges and
hydrogen bonds have important roles in protein structure
and function (Perutz, 1970; Barlow and Thornton, 1983;
Musafia et al., 1995; Xu et al., 1997a,b), and have been
linked to protein stability (Kumar et al., 2000; Yip et al.,
1998), and flexibility (Sinha et al., 2001a,b). Modification
of intramolecular salt bridges in HH10 alters its cross-
reactivity (Lavoie et al., 1992, 1999). Therefore, we hypoth-
esize that, among the three antibodies, HH26 has the most
rigid binding site, whereas HH8 has the most flexible bind-
ing site.
Surface plasmon resonance (SPR) analysis shows that the
association kinetics of HH-HEL binding of these three
complexes are best described by a two-step model (Lip-
schultz et al., 2000), which we interpret as an encounter
followed by a docking or annealing, which may involve
conformational rearrangements. The data also suggest that
the energy barriers to docking are lowest in the HH8-HEL
complex, highest in the HH26-HEL complex, and interme-
diate in HH10-HEL, especially in complexes with HEL
containing epitope mutations (Li et al., 2001; S. Mohan and
S. J. Smith-Gill, unpublished). Furthermore, among the
three complexes, HH8-HEL derives the greatest proportion
and amount of its free energy change from the docking step,
HH26-HEL the least, and HH10-HEL an intermediate
amount (Lipschultz et al., 2000; Li et al., 2001). Complex
stability, as measured by net dissociation rates, is more
sensitive to antigenic mutation in HH26 and HH10 com-
plexes than in HH8 (Lavoie et al., 1999; Li et al., 2001). In
addition, the three complexes differ in degree of sensitivity
of their initial association rates to mutation, with HH8 being
the least sensitive and HH26 the most (Lavoie et al., 1999;
Li et al., 2001; S. Mohan and S. J. Smith-Gill, unpublished).
Here we utilize a combination of computational and
experimental methods to examine in greater detail the struc-
tural and thermodynamic properties of these three com-
plexes, specifically testing the hypothesis that the number
and strength of electrostatic interactions influence associa-
tion at both intermolecular and intramolecular levels. The
former contributes directly to intermolecular complementa-
rity and free energy of binding (Sheinerman et al., 2000;
Kangas and Tidor, 2001), and the latter contributes indi-
rectly to specificity and affinity by modulation of protein
flexibility, or flexibility–rigidity compensations in general.
Here we show that, overall, the electrostatic component
dominates in HH26-HEL binding, and hydrophobicity dom-
inates in HH8-HEL binding. We show that the number of
short-range electrostatic interactions, the electrostatic
strengths, and the networking pattern of binding-site salt
bridges, and the overall electrostatic contributions toward
binding correspond to the association properties of these
antibodies. This indicates that the electrostatic properties
have striking functional significance in governing the flex-
ibility and rigidity with which protein–protein binds. We
also show that electrostatic interactions can have a differ-
ential impact on the encounter and docking steps of asso-
ciation. These results provide an insight into the structural
and thermodynamic manifestation of flexibility and rigidity.
MATERIALS AND METHODS
Antibody–antigen complexes
The coordinates for the HH10-HEL and HH10Fv-HEL complexes, and
unbound HEL, were obtained from the protein data bank (PDB) (Bern-
stein et al., 1977) (PDB ID: HH10-HEL, 3hfm; HH10Fv-HEL, 1c08;
HEL, 1bwh). HH10-HEL, HH10Fv-HEL, and unbound HEL were crys-
tal structures at 3.0-, 2.3-, and 1.8-Å resolutions, respectively. HH8-
HEL and HH26-HEL were theoretical structures, generated in this lab
(S. Mohan and S. J. Smith-Gill, submitted) using “Model Homologue”
module of LOOK software (Molecular Application Group) package.
The module uses the algorithm “segmod” (Levitt, 1992), which homol-
ogy models the target protein, using template structure, by optimizing
the packing interactions between the side chains. HH10-HEL was used
as a template to model HH8-HEL and HH26-HEL (S. Mohan and S. J.
Smith-Gill, submitted).
(PDB ID:3hfm) is shown. Heavy chain, light chain, and HEL are shown by purple, yellow, and red, respectively. Contact epitope and paratope residues
(Lavoie et al., 1999) are illustrated in green. Epitope and paratope residues are also shown by their side chains. The names and positions of epitope residues
are shown. Insight II (ACCELRYS) was used to generate the picture.
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Hydrogen bonds, salt bridges and buried
surface area
The presence of a hydrogen bond is inferred when two nonhydrogen atoms
with opposite partial charges are within a distance of 3.5 Å. Geometrical
goodness of H-bonds was assessed by computing the two angles: D
between vectors BD–D and D–A, where BD is covalently bonded to D; and
A between D–A and A–BA, where BA is covalently bonded to A.
Hydrogen-bonds with both the angles in the range of 90–150 were
considered to be of good geometry, and are listed here. Salt bridges are
inferred upon meeting the two criteria: the centroids of the oppositely
charged side-chain functional groups of charged residues (Asp, Glu, Lys,
Arg, and His) are within 4.0 Å; and Aspartate or glutamate side-chain
carbonyl oxygen atom is within 4.0 Å distance from nitrogen atom of
arginine, lysine or histidine side chains. When, for the same pair of
residues, there are more than one pair of nitrogen–oxygen atoms present
within 4.0 Å, the salt bridge has been counted only once. If a salt bridge
involves a CDR or an epitope residue, it is considered to be a binding-site
salt bridge.
Solvent-accessible surface area is calculated with a probe radius of 1.4
Å, using the algorithm of Lee and Richards (1971). The surface area buried
upon the complex formation is the difference in solvent-accessible surface
area between free and bound states:
ASA of free antibody  ASA of free antigen
 ASA of antibody–antigen complex.
Hydrophobicity
The method of Chothia (1974) was followed to estimate the hydrophobic
contribution to the free energy of binding. This method is based on the
observation that free energy of transferring an amino-acid side chain
from water to a nonpolar solvent (the hydrophobic effect) is directly
proportional to the solvent-accessible surface area of the side chains
(Rose et al., 1985), where 1 Å2 of buried surface corresponds to 25 cal
of hydrophobic stabilization. Buried surface area upon complex forma-
tion was calculated as described above. The hydrophobic contribution
was calculated as Ghydro (kcal/mol)  (Area buried upon the complex
formation  25)  1000.
Electrostatic contributions of salt bridges
We have computed the electrostatic strength of salt bridges using a con-
tinuum electrostatic approach to solve the linearized Poisson–Boltzmann
equation, using the DELPHI computer program developed by Honig and
co-workers (Gilson et al., 1985; Gilson and Honig, 1987). The method has
been widely used (Hendsch and Tidor, 1994; Xu et al., 1997a; Lounnas and
Wade, 1997; Sinha et al., 2001a) and experimentally supported (Wald-
burger et al., 1995, 1996). The electrostatic contribution of a salt bridge to
the free energy of folding is calculated as described by Hendsch and Tidor
(1994). The electrostatic strength of a salt bridge is measured relative to
computer mutation of salt-bridging side chains to their hydrophobic
isosters. A hydrophobic isoster is the salt-bridging side chain with its
partial atomic charges set to zero (Hendsch and Tidor, 1994). Side chain
alone in solution was used for the unfolded state, which was therefore used
as a reference state. The electrostatic contributions of salt bridges are
calculated for folded state, as compared to the unfolded state. The electro-
static strength of a salt bridge can be divided into three component terms:
Gdesol, the sum of the charge desolvation penalties paid by the salt-
bridging side chains, when they are brought from the dielectric of 80.0 (in
water) to the dielectric of 4.0 (in the protein interior); Gbridge, the
favorable energy change due to electrostatic interaction between opposite
charges of salt-bridging side chains; and Gprotein, electrostatic interac-
tions of salt-bridging side chains with the charges in the rest of the protein.
The total electrostatic energy upon the salt-bridge formation would be
Gtot  Gdesol  Gbridge  Gprotein. (1)
The DELPHI software package calculates the electrostatic potential in and
around macromolecules, using the iterative finite difference solution to the
Poisson–Boltzmann equation. The desolvation penalty, bridge term, and
protein term were calculated as described by Hendsch and Tidor (1994).
The desolvation penalty of a salt-bridging side chain upon protein folding
was computed by setting the partial charges of all atoms, except ones in the
salt-bridging side chain, to 0. The reaction field energy was calculated for
each salt-bridging side chain, with its respective partial charges on. The
charge desolvation was computed similarly in the unfolded state. Thus, in
the unfolded model, the salt-bridging side chains are present in solvent, and
are infinitely separated from each other. The coordinates for salt-bridging
side chains are taken from x-ray structure, and, for unfolded-state calcu-
lation, these were placed at exactly the same position on the finite-
difference grid as they occupy in the folded state. For each of the salt-
bridging side chains, the reaction field energy in the unfolded state was
subtracted from the reaction field energy in the folded state to give the
charge desolvation penalty. The sum of the charge desolvation penalties of
both side chains is the charge desolvation penalty of the salt bridge,
Gdesol.
For electrostatic interactions between salt-bridging side chains, the
linearized Poisson–Boltzmann equation was solved after setting all the
partial charges of the molecule to 0, except those on one of the salt-
bridging side chains. The potential at each partial charge position on the
other side chain was determined to estimate the bridge term,
GBridge  
i
iqi, (2)
where  is the potential, and q is magnitude at i partial charge of the other
side chain.
The contribution due to charge interactions between salt-bridging side
chains and the rest of the protein is estimated by solving the Poisson–
Boltzmann equation in the folded state, with atomic charges, except for
those in salt-bridging side chains, set to 0. The protein term, GProtein, is
calculated as
GProtein  
i
iqi, (3)
where i ranges over all partial charges in whole protein, excluding charged
atoms of salt-bridging side chains.
The strength of pentad and triad salt-bridge networks were computed
considering each as a unit. The electrostatic strength of the salt-bridge
network was computed similarly, by taking into account the charge
desolvation penalty of all interacting side chains, all possible electro-
static interactions and the protein term. A salt-bridge network will have
favorable and unfavorable interactions, between opposite and like charges,
respectively.
The protein structure was mapped on 79  79  79 point 3-dimensional
grid for iterative finite difference calculations. The grid spacing was kept
0.83 Å. Hydrogen atoms were added to the structures, and the protonation
state of the charged residues were defined at pH 7.0, using the BIOPOLY-
MER module of INSIGHT II (ACCELRYS). PARSE3 set of atomic
charges and radii (Sitkoff et al., 1994) were used, with a solvent probe
radius of 1.4 Å. The dielectric constant of solute (protein) was kept at 4.0
and that of solvent was kept at 80.0. The ionic strength of 145 mM was
used to simulate the physiological conditions. The output energy value in
units kT, where k is the Boltzman constant and T is the absolute temper-
ature, were multiplied with the conversion factor 0.592 to obtain the results
in kilo-calories per mole at the room temperature, 25°C. For each calcu-
lation, the structures were first mapped on the grid where the molecule
occupied 50% of the grid and Debye–Huckel boundary conditions were
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applied (Klapper et al., 1986). The resulting rough calculations were used
as a boundary condition for focused calculation, where molecule extent
was kept 95% on the grid. The results of focused calculations are shown
here.
Electrostatic contribution to antibody
antigen binding
The electrostatic contributions are calculated as the sum of charge desol-
vation penalties paid by antibody and antigen upon complex formation plus
their electrostatic interactions. The electrostatic contributions were calcu-
lated for bound state, compared to the unbound. The reference state used
here was unbound state. The continuum electrostatic approach was used to
solve the linearized Poisson–Boltzmann equation, by means of the finite
difference method, as described above, using DELPHI software.
Point mutation
Structures with alanine mutations were generated using the “Mutant Mod-
eling” module of the software package LOOK3.0 (Molecular Applications
Group, Palo Alto, CA). This module used an algorithm ‘cara’ (Lee and
Subbiah, 1991), which models the side-chain conformation of substituted
residues and the residues with which it contacts. The method applies the
simulated annealing algorithm to optimize side-chain Van der Waals
interactions. The predictions using this method have been shown to be
accurate, particularly for nonsurface residues (Lee and Subbiah, 1991).
Lysine was substituted with alanine in the sequence. This sequence was
used as a new sequence to generate a model, using the original structure as
template. The new mutant was used for binding energy calculations.
Binding kinetics
HEL or single-site mutants were expressed and purified in Pichia pastoris
(Li et al., 2000, 2001), and immobilized on a CM5 sensor chip. Recom-
binant Fab (Li et al., 2001) was used as analyte, and the binding was
monitored by SPR, using a BIAcore1000 or BIAcore2000 instrument. The
rate constants for encounter (k1, k	1) and docking (k2, k	2) were cal-
culated by global analysis of the binding curves, using a two-step model
and BIAeval3.02 software, as described and detailed elsewhere (Lipschultz
et al., 2000; Li et al., 2001), and used to calculate affinities for encounter
(Ka1  k1/k	1), docking (Ka2  k2/k	2) and the total binding (K 
Ka1(1  Ka2)). Gibbs free energy change for each equilibrium constant
(encounter, G1; Docking, G2; Total, G) was calculated using the
relationship: G  	RT ln(Ka). G, the change in free energy due to a
given mutant, was calculated as:
G Gmut  GHEL.
RESULTS
Hydrogen bonds at the antibody–antigen
binding interface
S. Mohan and S. J. Smith-Gill (submitted) reported that,
among the three antibodies, HH8Fv has the fewest and
HH26Fv has the largest number of intermolecular hydrogen
bonds and Van der Waals contacts in their respective com-
plexes with HEL. Using different criteria (see Materials and
Method) and the distance cut-offs (3.5 versus 3.0 Å) for
H-Bond detection, we also find the same ranking among the
three HH-HEL complexes for intra- and intermolecular hy-
drogen bonds (Table 1; Appendix). Among the three, only
HH26-HEL complex contains an intermolecular main
chain–main chain hydrogen bond, connecting Asp-92L (The
subscript represents chain ID throughout the text: H, heavy
chain; L, light chain; Y, lysozyme.) to epitope residue
Arg-21Y (Fig. 2 f), implying close intermolecular associa-
tions. Epitope residue Arg-21Y is a hot-spot of HH-HEL
binding (Pons et al., 1999; Li et al., 2000, 2001), and, among
the three antibodies, HH26 is most sensitive toward the muta-
tions of this residue (Lavoie et al., 1999). Our results are
consistent with previous reports that the interactions in anti-
body–antigen complexes are mainly via side chains, in contrast
to interactions in proteinase–proteinase inhibitors, which are
via main-chain atoms (Jackson, 1999). The ranking of the
number of intra- and intermolecular hydrogen bonds (HH8 
HH10HH26) suggests that nonbonded interactions are least
rigorous in HH8-HEL, most rigorous in HH26-HEL, and are
intermediate in HH10-HEL.
Intramolecular salt bridges
Computational and experimental analysis have shown that
salt bridges can be stabilizing (Marqusee and Sauer, 1994;
Xu et al., 1997a; Lounnas and Wade, 1997) or destabilizing
(Hendsch and Tidor, 1994; Sun et al., 1991). Thermophilic
proteins have stronger salt bridges than their mesophilic
counterparts (Yip et al., 1998; Kumar et al., 2000), indicat-
ing the functional significance of strong salt bridges. Elec-
trostatic strength of salt bridges have been linked to protein
flexibility (Sinha et al., 2001a,b). The three HH-HEL com-
plexes were computed for the number and electrostatic
strength of salt bridges. The electrostatic strengths of salt
bridges were computed using the continuum electrostatic
method described by Hendsch and Tidor (1994). This
method, widely used to quantitatively estimate electrostatic
potentials, pH-dependent properties, and solvation free en-
ergies (Honig and Nicholls, 1995), models proteins in
atomic details and treats solvent as a bulk. The three com-
ponents of salt-bridge strength (Hendsch and Tidor, 1994)
TABLE 1 Hydrogen bonds at CDRs and Epitope
H-bond*
Type
HH8-HEL HH10-HEL HH26-HEL
Intra Inter Total Intra Inter Total Intra Inter Total
MC-MC† 24 None 24 35 None 35 34 1 35
MC-SC‡ 35 2 37 28 3 31 33 4 37
SC-SC§ 2 1 3 3 2 5 3 3 6
Total 61 3 64 66 5 71 70 8 78
Summary of the number of hydrogen bonds present at the CDRs and
epitope regions of HH8-HEL, HH10-HEL, and HH26-HEL complexes.
Appendix provides the details.
*Hydrogen-bond.
†Main-chain–main-chain.
‡Main-chain–side-chain.
§Side-chain–side-chain.
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FIGURE 2 Salt bridges at the binding in-
terface of HH8-HEL, HH10-HEL, and
HH26-HEL complexes. (a) HH8-HEL: An
intermolecular and two intramolecular salt
bridges. (b) HH10-HEL: An intramolecular
triad and an independent intramolecular salt-
bridge. (c) Pentad present at the HH26-HEL
binding interface. Intermolecular triad net-
worked with intramolecular triad forms this
pentad. The other two salt bridges present at
the HH26-HEL interface (Table 2) are not
shown in this picture. Salt bridges are shown
as they map in the protein structure, whether
networked or independent. Residues forming
salt bridges are labeled: L, light chain; H,
heavy chain; Y, HEL. Residue positions fol-
low the chain names, which are followed by
three-letter residue code. Distances between
salt-bridge forming side-chains are shown in
. (d, e, f) The complexity of salt-bridge
interactions at the binding interfaces of (d)
HH8-HEL, (e) HH10-HEL, and (f) HH26-
HEL. Heavy chains are shown in purple,
light-chains in yellow, and HEL in red. Salt-
bridge-forming residues are shown in green
and by their side chains. Residues forming an
intermolecular (between light chain and
HEL) main chain–main chain hydrogen bond,
in the case of HH26-HEL, are shown in light
blue and by their side chains. Picture is gen-
erated using Insight II package.
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are salt-bridge interaction with solvent, electrostatic inter-
action between salt-bridging side chains, and salt-bridge
interaction with the charges in the rest of the protein.
S. Mohan and S. J. Smith-Gill (submitted) reported that,
among the three antibodies, the HH8-HEL complex had the
fewest and HH26-HEL complex the largest number of in-
tramolecular salt bridges in the Fv regions. They hypothe-
sized that the differences in the number of intramolecular
salt bridges account for differences in flexibilities and pack-
ing densities among the three Fvs. Using more stringent
criteria for detecting salt bridges (see Materials and Meth-
ods) we also found that the HH8-HEL complex has fewer
intramolecular salt bridges than either the HH10-HEL or
HH26-HEL complexes (Table 2). In addition, the strengths
of the intramolecular salt bridges at the binding site differ
among the three complexes, being weakest in HH8-HEL
and strongest in HH26-HEL (Table 3).
An intramolecular salt bridge, Lys-49L—Asp-101H was
identified in HH10-HEL and HH26-HEL complexes by
Mohan and Smith-Gill. This interaction did not qualify as a
salt bridge according to our criteria (see Materials and
Methods). We have computed the electrostatic strengths of
this ion pair to estimate the qualitative differences in these
complexes. This ion pair is very strong, 	14.956 kcal/mol,
in HH26-HEL and only marginally stabilizing, 	0.106
kcal/mol, in HH10-HEL. The very high stability of this
ion-pair in HH26-HEL is mainly due to the very favorable
protein term of HH26-HEL.
Salt-bridge networks and electrostatic forces at
the antibody–antigen interface
The numbers, electrostatic strengths, arrangement complexi-
ties, and the degree of networking of salt bridges at the binding
interface vary among the three complexes (Table 3, Fig. 3).
HH8-HEL has one intermolecular salt bridge, and HH26-HEL
has two, which are networked. The single intermolecular salt
bridge, Asp-32H—Lys-97Y, in HH8-HEL is only marginally
stabilizing with an electrostatic strength less than 	2.0 kcal/
mol (Table 3). In contrast, this salt bridge contributes nearly
	8.0 kcal/mol in HH26-HEL complex (Table 3). The second
intermolecular salt bridge in HH26-HEL also involves Lys-
97Y, and contributes over 	11.0 kcal/mol. The electrostatic
contribution correlates well with alanine scanning data, which
show that Lys-97Y is a hot-spot residue (contributing 	4.0
kcal/mol or more to the binding energy) in the epitopes of
HH10, HH26, and the related antibody HH63 (Pons et al.,
1999; Li et al., 2000), but contributes only slightly over 	1
kcal/mol in the HH8 complex (see next section).
HH10-HEL was reported to contain the Asp-32H—Lys-
97Y intermolecular salt bridge (Padlan et al., 1989), based
on the criterion that their oppositely charged atoms were
present within a 3.4-Å distance. This interaction does not
meet the two criteria of our method (see Materials and
Methods) to qualify as a salt bridge in HH10-HEL complex.
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First, the O1 atom of aspartate was not within the 3.4-Å
distance from N	 atom of lysine; the distance was found to
be 3.6 Å. Second, although the distance was within 4 Å, a
limit set in our method, the distance between the centroid of
their opposite-charged groups were more than 4.0 Å. How-
ever, there is still an electrostatic interaction between these
TABLE 2 Salt bridges in antibody variable domain–HEL complexes
Salt Bridge Corresponding Regions
Complex
HH8-HEL HH10-HEL HH10Fv-HEL HH26-HEL
Inter-molecular
Asp-32H–Lys-97Y CDR1-Epitope ✓ – ✓ ✓
Glu-99H–Lys-97Y CDR3-Epitope – – – ✓
Intra-molecular
Lys-64H–Glu-88H CDR2-Frame (B)* ✓ – – –
Arg-66H–Asp-89H Frame ✓ ✓ ✓ ✓
Arg-24L–Asp-70L CDR1-Frame (B) ✓ ✓ – ✓
Arg-61L–Glu-79L Frame ✓ ✓ ✓ –
Arg-61L–Asp-82L Frame ✓ ✓ ✓ ✓
Arg-38H–Glu-46H Frame – ✓ – –
Asp-99H–His-34L CDR3-CDR1 (B) – ✓ – –
Asp-99H–Lys-49L CDR3-CDR2 (B) – ✓ – –
Lys-39L–Glu-42L Frame – ✓ – –
Lys-39L–Glu-81L Frame – ✓ – –
Lys-103L–Glu-105L Frame – ✓ – –
Lys-1Y–Glu-7Y HEL – ✓ ✓ –
Asp-119Y–Arg-125Y HEL – ✓ – ✓
Asp-72H–Lys-75H Frame – – ✓ –
Asp-48Y–Arg-61Y HEL (B) – – ✓ ✓
Arg-97H–Glu-99H Frame-CDR3 (B) – – – ✓
Arg-97H–Asp-101H Frame-CDR3 (B) – – – ✓
Glu-42L–Arg-45L Frame – – – ✓
Asp-66Y–Arg-68Y HEL – – – ✓
Salt bridge-forming residues are shown by their names, followed by the residue positions, followed by chain identifications. Criteria for salt-bridge detection
is as described in text.
*Binding site; only shown in cases of intramolecular salt bridges.
TABLE 3 Electrostatic contributions of salt bridges present at the binding site
Complex Salt Bridge*
Gdesolve
(kcal/mol)
Gbridge
(kcal/mol)
Gprotein
(kcal/mol)
Total (Gelect)
(kcal/mol)
Intermolecular salt bridges (between antibody and hen egg white lysozyme)
HH8-HEL Asp-32H–Lys-97Y 10.89 	8.25 	4.64 	2.00
HH10Fv-HEL Asp-32H–Lys-97Y 19.02 	13.37 	18.72 	13.07
HH26-HEL Asp-32H–Lys-97Y 17.36 	11.46 	13.68 	7.78
HH26-HEL Glu-99H–Lys-97Y 16.37 	11.80 	16.05 	11.48
Intramolecular salt bridges (binding region)
HH8-HEL Lys-64H–Glu-88H 8.73 	6.43 	3.05 	0.75
HH8-HEL Arg-24L–Asp-70L 0.80 	1.70 	0.38 	1.28
HH10-HEL Asp-99H–His-34L 15.06 	5.91 	8.09 1.06
HH10-HEL Asp-99H–Lys-49L 18.89 	11.50 	13.79 	6.40
HH10-HEL Arg-24L–Asp-70L 1.22 	1.89 	0.12 	0.79
HH10Fv-HEL Arg-66H–Asp-89H 12.68 	7.35 	10.93 	5.60
HH10Fv-HEL Asp-48Y–Arg-61Y 10.09 	1.66 	8.43 	0.01
HH26-HEL Arg-97H–Glu-99H 12.92 	4.74 	20.44 	12.26
HH26-HEL Arg-97H–Asp-101H 11.49 	12.54 	12.60 	13.65
HH26-HEL Arg-24L–Asp-70L 1.24 	1.80 	0.23 	0.79
HH26-HEL Asp-48Y–Arg-61Y 6.15 	4.71 	5.82 	4.38
The electrostatic contributions for intermolecular salt bridges and for those that are present at the binding site to the free energy of folding, calculated using
continuum electrostatic approach, using finite difference methods to solve Poisson–Boltzmann equation, using DELPHI computer program developed by
Honig and co-workers (Gilson et al., 1985; Gilson and Honig, 1987). If a salt bridge involves at least one residue either from epitope or from any of the
CDRs, it is considered to be present at the binding site.
*Salt bridge-forming residues are shown. Residue names are followed by their positions, which are followed by chain identifications.
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two residues, forming an ion pair, but its electrostatic
strength is insignificant (0.07 kcal/mol).
The recently solved crystal structure of HH10Fv domain
complexed with HEL, at 1.8-Å resolution (Kondoi et al., 1999)
shows that the intermolecular salt bridge, Asp-32H–Lys-97Y,
not present in HH10Fab-HEL, is present in HH10Fv-HEL
(Table 2). In addition, HH10Fv-HEL buries a larger proportion
of surface area and has more favorable interactions than the
HH10Fab-HEL complex (Kondoi et al., 1999), and has minor
conformational differences from HH10Fab-HEL at the binding
interface (Kondoi et al., 1999). Analysis of intramolecular salt
bridges shows that the HH10Fv-HEL complex also has fewer
intramolecular salt bridges within the Fv than either of the
three Fab-HEL complexes, and includes one between frame-
work residues that is unique to that complex (Tables 2 and 3).
Because the affinity of the HH10Fv-HEL complex is signifi-
cantly lower than that of the HH10Fab-HEL complex (Kondoi
et al., 1999), it may not be a representative of the molecular
interactions of either HH10-Fab or HH10-Ig with HEL, even
though the structure is of higher resolution. It has been sug-
gested that the unfavorable effect of removing the constant
region was compensated by favorable interactions between
HH10 and HEL, in the case of HH10Fv-HEL complex (Kon-
doi et al., 1999). Nonetheless, the presence of the intermolec-
ular salt bridge in the HH10Fv-HEL complex indicates an
electrostatic interaction between these two residues. In addi-
tion, our Ala scanning data (next section) indicates that Lys-
97Y contributes 
	4.0 kcal/mol to binding, and HH10Fab-
HEL double-mutant cycle analysis suggests a significant
energetic interaction between Lys-97Y and Asp-32H (Pons et
al., 1999).
In HH8-HEL, there are no salt-bridge networks, and the
electrostatic strengths of the binding site salt bridges are
very low (Table 3). In HH10-HEL, the two CDR inter-chain
salt bridges are networked to form a triad, with relatively
high electrostatic contributions. One of the salt bridges of
the intramolecular triad is significantly stabilizing, and the
other is marginally destabilizing. The total electrostatic
strength of the triad is significantly high (Table 4).
Two intramolecular salt bridges in HH26-HEL form a triad,
and are further networked with an intermolecular triad to form
a pentad (Fig. 2 c). All salt bridges of this network are strongly
stabilizing (	7.78 kcal/mol or more), suggesting a functional/
structural significance of the pentad. The total electrostatic
strength of the pentad is very high (Table 4), as expected,
because all four salt bridges within this network are strongly
stabilizing (Table 3). Table 4 summarizes the components of
the pentad electrostatic strength, and their electrostatic contri-
butions. The pentad is considered as a unit, and its electrostatic
strength is computed as described for salt bridges (see Mate-
rials and Methods). We have computed the bridge terms for all
possible electrostatic interactions present in the pentad (Table
4). It is clear from Table 4 that destabilization due to unfavor-
able interactions between like charges is much smaller than the
stabilization due to the favorable interactions between opposite
charges. In the case of the triad, present in HH10-HEL, the
FIGURE 3 Plot showing the elec-
trostatic strengths of the salt bridges
present at the HH8-HEL (blue),
HH10-HEL (cyan), HH10Fv-HEL
(yellow), and HH26-HEL (red)
binding interfaces. Electrostatic
strength of salt bridges (Gtot) is
shown in kcal/mol. The numbers on
the x axis represents the following
salt bridges: 1, D32H-K97Y; 2,
E99H-K97Y; 3, K64H-E88H; 4,
R24L-D70L; 5, D99H-H34L; 6,
D99H-K49L; 7, R97H-E99H; 8,
R97H-D101H; 9, D48Y-R61Y; 10,
R66H-D89H (first character is one-
letter residue code, followed by res-
idue position, which is followed by
the chain identification). *, Intermo-
lecular salt bridge.
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destabilization due to unfavorable interaction is also high (Ta-
ble 4). Electrostatic interaction of the pentad with the rest of the
protein is also very favorable (Table 4). The strong electro-
static strength further corroborates the functional value of
pentad, and the constituent salt bridges. It is possible that this
pentad is acquired during the affinity maturation of the HH26
antibody, and is a major determinant of the high HH26-HEL
binding specificity.
Only the HH26-HEL complex has an intramolecular salt
bridge, Asp-48Y–Arg-61Y (also present in HH10Fv-HEL).
This ion pair is also present in uncomplexed HEL. (Table 3,
Fig. 3), in the epitope region of HEL, which is significantly
stabilizing. In HH10Fv-HEL, the intermolecular salt bridge,
Asp-32H–Lys-97Y is significantly stabilizing, but is not
networked. One intramolecular salt bridge is stabilizing, but
the other intramolecular salt bridge, Asp-48Y–Arg-61Y,
present at the HEL binding site, is almost neutral.
The desolvation penalties, the bridge terms and the protein
terms of the salt-bridge formation vary among the three com-
plexes. Salt bridges in HH8-HEL pay lower desolvation pen-
alties than salt bridges in HH10-HEL and HH26-HEL com-
plexes. HH26-HEL salt bridges pay the highest desolvation
penalties. Yet, this heavy penalty in HH26-HEL is compen-
sated by very favorable bridge and protein terms. In HH10-
HEL, on average, bridge and protein terms are more favorable
than the HH8-HEL and less favorable than HH26-HEL. The
bridge and protein terms in HH8-HEL salt bridges are only
moderately favorable. The more a salt bridge is buried, the
higher desolvation penalty it pays, but it will have stronger
electrostatic interactions due to absence of solvent screening.
The extent of the electrostatic protein environment will further
determine the robustness of the charge–charge interactions
between the salt-bridging side chains.
The higher number of salt bridges, the networking of very
strong salt bridges, the preservation of the intramolecular
salt bridge at the binding site of HEL, which is absent in
HH8-HEL and HH10-HEL complexes, indicate an inher-
ently electrostatic binding of HH26-HEL, which is likely to
be a significant factor for high binding specificity of HH26
toward HEL. In contrast, weak electrostatic interactions
may predispose HH8-HEL binding to be less specific. The
weak electrostatic component of HH8-HEL binding implies
an inherent flexible nature of the HH8-HEL binding site.
Electrostatic and hydrophobic components
of binding
Conformationally flexible parts have relatively lower electro-
static interactions, and substantial hydrophobic interactions
(Sinha et al., 2001a,b). We have examined the total electro-
static and hydrophobic contributions to the free energy of
HH8, HH10, and HH26 binding to HEL (Table 5). Both
antigen and antibody pay heavy charge desolvation penalties
upon binding in all three complexes, but there are large differ-
ences among the three complexes in the electrostatic compo-
nents of binding. HH10-HEL has significantly favorable elec-
trostatic component in comparison to HH8-HEL, but it is less
favorable in comparison to HH26-HEL. HH10-HEL and
HH26-HEL are more similar to each other than to HH8-HEL.
Their desolvation penalties are higher than that of HH8 by 4–5
kcal/mol, and they differ from each other by only 1 kcal/mol.
HH10 and HH26 have	7.0 to	10.0 kcal/mol more favorable
electrostatic interactions with HEL than HH8 with HEL, with
a difference between them of 	3.0 kcal/mol. Overall, the
electrostatic contribution to the free energy of binding is lowest
in HH8-HEL, intermediate in HH10-HEL, and highest in
HH26-HEL. Among the three complexes, HH8-HEL has larg-
est hydrophobic contributions. Compared to the differences in
TABLE 4 Electrostatic contribution of Triad in HH10-HEL
and Pentad in HH26-HEL
Triad
Desolvation penalty (Kcal/M)
Residue side chain Penalty Total
Asp-99H 8.82
His-34L 3.37
Lys-49L 8.04 20.23
Bridge terms (Kcal/M)
Interaction type Bridge term Total
Asp-99H–Lys-49L 	11.50
Asp-99H–His-34L 	5.91
Lys-49L–His-34L 6.65 	10.76
Protein term (Kcal/M)
Interaction Protein term
Triad–rest of the protein 	15.75 	15.75
Total electrostatic strength of Triad (Kcal/M) 	6.28
Pentad
Desolvation penalty (Kcal/M)
Residue side chain Penalty Total
Asp-32H 5.94
Lys-97Y 7.64
Glu-99H 4.84
Arg-97H 2.58
Asp-101H 4.80 25.80
Bridge term (Kcal/M)
Interaction type Bridge term Total
Asp-32H–Lys-97Y 	11.49
Asp-32H–Glu-99H 4.00
Asp-32H–Arg-97H 	3.57
Asp-32H–Asp-101H 1.27
Lys-97Y–Glu-99H 	11.89
Lys-97Y–Arg-97H 2.92
Lys-97Y–Asp-101H 	1.54
Glu-99H–Arg-97H 	4.80
Glu-99H–Asp-101H 3.43
Arg-97H–Asp-101H 	12.59 	34.26
Protein term (Kcal/M)
Interaction Protein term
Pentad–rest of the protein 	24.86 	24.86
Total electrostatic strength of Pentad (Kcal/M) 	33.32
Electrostatic contribution of salt-bridge networks in HH10-HEL and
HH26-HEL complexes. Charge desolvation penalty is computed for all the
side chains. All possible electrostatic interactions in the network were
computed for their potentials. Method is detailed in Materials and Methods
section. Residue names are followed by their positions, which is followed
by chain identifications.
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electrostatic contributions, the hydrophobic contributions are
similar among all the complexes and their mutants. Significant
differences are in electrostatic contributions. The finding is
consistent with the earlier result that HH26 is more electro-
static in nature. We hypothesize that higher electrostatics make
HH26 binding site more rigid and less cross-reactive.
Binding of HH8, HH10, and HH26 to Lys-97ala
and Lys-96ala mutants of HEL
Previous alanine scanning mutagenesis showed that only
three hot-spot epitope residues contribute more then 4 kcal/
mol to the free energy of HH10-HEL complex formation
(Pons et al., 1999). These three residues were reported to be
Lys-97Y, Lys-96Y and Tyr-20Y, where Lys-96Y contributed
the most, based on enzymatic activity assay (Pons et al.,
1999). We modeled alanine mutants of the two charged
epitope residues, Lys-96Y and Lys-97Y and calculated their
electrostatic and hydrophobic components of binding. The
impacts of these mutations on binding kinetics were also
measured by SPR using site-directed mutants of
HEL(K96A) and HEL(K97A). These two sequentially ad-
jacent charged residues were particularly selected because,
although adjacent residues on HEL, only Lys-97Y forms an
intermolecular salt-bridge, and because these two residues
have been shown experimentally to be the hot-spots of
binding (Pons et al., 1999). The analysis of the charged
hot-spot mutants would allow straightforward estimation of
the qualitative differences in the electrostatic properties of
the three complexes.
SPR results confirm previous findings that Lys-97Y is a
hot spot residue in all three complexes, but showed that the
energetic contribution of Lys-96Y to binding is insignificant
(Table 5). In fact, SPR studies show that, among all the
epitope residues, Lys-97Y contributes the largest amount to
the free energy of binding in HH10-HEL and HH26-HEL
complexes (S. J. Smith-Gill, C. A. Lipschultz, Y. Li, and S.
Mohan, unpublished results). For HEL(K97A) complexes,
G ranked HH8  HH10  HH26 (Table 5). For all three
antibodies, the greatest impact of Lys-97Y mutations on free
energy change is at the encounter step of association (Fig.
4), which is consistent with the view that electrostatic forces
play an important role in steering and orienting the mole-
cules to form the encounter complex (Sines et al., 1990;
Kozack et al., 1995; Antosiewicz and McCammon, 1995;
Janin, 1997). The impact of HEL(K97A) mutation on free
energy change of HH8 docking is insignificant (G2 
0.5 kcal/mol). Experiments based on a lysozyme enzymatic
activity assay (Pons et al., 1999) reported Lys-97Y to con-
tribute less then Lys-96Y. The discrepancy may be due to
the different buffer and pH conditions used, which may
affect the protonation states of the charged groups. In an
earlier study, it has been shown that the binding of HH10 to
HEL with the mutants of charged epitope hot-spot residues
is significantly pH dependent, where the shifts in pKas due
to mutations would result in proton uptake or release (Sharp,
1998). Additionally, SPR results are directly calculated
from binding data (at pH 7.4), whereas the results of Pons et
al. (1999) are derived indirectly by estimating free lysozyme
via enzymatic activity, at pH 6.0.
Examination of the individual rate constants (Fig. 5, a–c)
shows that the mechanisms underlying the encounter ther-
modynamic changes differ among the antibodies. For the
HH8-HEL(K97A) complex, the association and dissocia-
tion rate constants of the encounter step (k1 and k	1), are
slowed and increased by 2–2.5 fold, respectively (Fig. 5 a),
resulting in a net loss of 
	1.0 kcal/mol from the encoun-
ter step (Fig. 4 a). The lower k1 reflects a small increase of

0.5 kcal/mol in activation energy for encounter (Fig. 4 b),
whereas loss of 
1 kcal/mol from G1 and slightly higher
TABLE 5 Binding free energies and their electrostatic and hydrophobic components
Complex Experimental (SPR) Desolvation
Gel Ghydro Gm(eh)	w(eh)Antigen Antibody G Gm	w Antibody HEL Total
HEL HH8 	13.8 24.24 25.84 50.08 	13.31 	47.95
HH10 	13.1 24.28 31.68 55.96 	20.66 	44.05
HH26 	10.4 28.19 26.51 54.70 	23.88 	46.16
HEL(K96A) HH8 	13.1 0.7 21.63 20.94 42.57 	7.15 	47.62 	1.02
HH10 	12.8 0.3 23.05 23.44 46.49 	13.33 	44.03 	2.12
HH26 	10.8 	0.3 26.34 24.26 50.60 	13.90 	45.92 6.12
HEL(K97A) HH8 	12.300 1.4 21.52 23.20 44.72 	5.50 	48.17 2.23
HH10 	9.000 4.1 24.24 23.80 48.04 	6.10 	43.99 6.70
HH26 	6.800 3.6 26.11 22.29 48.40 	2.91 	47.35 13.48
Binding free energies and their components are in kcal/mol. Gm(eh)	w(eh) is calculated only taking into account the electrostatic and hydrophobic
components. Our purpose is to have a qualitative estimate of the effects of Lys-97Y and Lys-96Y mutants on the three HH-HEL complexes. Our calculations
correspond qualitatively to experimental observations that the Lys-97YAla mutants affect the binding more severely than Lys-96YAla mutant.
Gdesol is the charge desolvation penalty.
Gel is the electrostatic energy between antibody and antigen (equivalent to the bridge term in salt bridge free energy calculations).
Ghydro is the hydrophobic component of the free energy of binding.
The calculations were performed as described in the text.
2956 Sinha et al.
Biophysical Journal 83(6) 2946–2968
k	1 suggests that encounter complex is also less stable than
that of HEL complex. This is reflected in the higher T50,
which is a measure of the biological half-life of conversion
of encounter complex to docked complex (Fig. 6, a and d).
The apparently faster net off-rate (Fig. 5 d) reflects a higher
proportion of complexes in the less stable encounter state
(Fig. 6 d).
In contrast to the HH8-HEL(K97A) complex, although
the encounter association rate constants (k1) of the HH10-
HEL(K97A) and HH26-HEL(K97A) complexes are slowed
by about the same order of magnitude as that of HH8-
HEL(K97A) (
5 and 2.5, respectively), the encounter
dissociation constants (k	1) of both complexes are in-
creased by about 20-fold (
25 and 18, respectively)
(Fig. 5, b and c). In both the HH10-HEL and HH26-HEL
complexes, the loss of Lys-97 destabilizes the encounter
complex (Fig. 5, b and c) and increases the activation
energy required for encounter (Fig. 4 b). The loss of the
electrostatic interaction with Lys-97Y increases the encoun-
ter activation energy of HH10-HEL more than that of
HH26-HEL complex, and increases the docking activation
energy of HH26-HEL more than that of HH10-HEL com-
plex (Fig. 4 b). The effects on the rate constants for the
docking step are less dramatic, with 2–4-fold decrease in
k2 and a 2–4-fold increase in k	2 (Fig. 5, b and c). In both
complexes, the large increase in k	2, coupled with smaller
decrease in k2, results in k2  k	1, and the rate-limiting
step is shifted from the encounter to docking, consistent
with the increase in the activation energy for docking in
FIGURE 4 The binding kinetics of these mAbs conformed well to a
two-step kinetic model describing an “induced fit” binding mode
A  B9|=
k1
k	1
AB9|=
k2
k	2
AB.
To obtain estimates of the rate constants, a data set containing association
times (Ta) of at least two durations (Lipschultz et al., 2000) was analyzed
globally to obtain estimates of rate constants. The parameters k1, k	1,
k2, k	2, and Rmax were estimated with BIAeval 3.0.2 software (Biacore,
Inc., Uppsala, Sweden), which uses the Marquat–Levenberg algorithm to
simultaneously iteratively fit binding data of all curves within a given data
set (global fit) to simultaneous rate equations,
dB
dt  k	1  AB*  k1  A  B,
dAB*
dt  k1  A  B  k	1  AB*
 k2  AB*  k	2  AB,
dAB
dt  k2  AB*  k	2  AB,
where B(0)  Rmax, [AB]*(0)  AB(0)  0, and total RU  [AB]*  AB.
Error terms were all less than 5% of the mean. Calculations were per-
formed carrying three significant figures. Equilibrium constants were cal-
culated from the mean rate constants (Krauss et al., 1976; Barre et al.,
1994; Lipschultz et al., 2000).
Ka1 
k1
k	1
; Ka2 
k2
k	2
; and KA  Ka11  Ka2.
(a) Free energy changes were calculated from the equilibrium constants
(Lipschultz et al., 2000; Li et al., 2001)
G1 	RT lnKa1
G2 	RT lnKa2,
G G1  G2.
In all cases, total G calculated as above did not differ from G calculated
directly from overall equilibrium constant KA. (b) The activation energies
for the encounter and docking stages (G1I¨ and G2I¨) were calculated
from k1 and k2, respectively (S. Mohan et al., submitted), where,
according to the transition state theory,
GI¨ 	RT inKI¨,
GI¨ 	RT inKmutI¨ /KHELI¨ ,
where KI¨  kBTka/, ka is the forward rate constant, kB is Boltzmanns
constant and  is Planck’s constant.
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both complexes (Fig. 4 b). Thus, a smaller proportion of the
complexes actually dock, and stabilities of the docked mu-
tant complexes are lower than the stabilities of docked HEL
complexes (Fig. 5, h and i and Fig. 6, e and f). The relative
overall impact of the mutations on steering is related to the
product k1k2, whereas the stability of encounter complex is
proportional to 1/k	1 (Selzer and Schreiber, 2001). The
mutation K97A affects the stability and the steering by
about the same order of magnitude for each of the HH8-
HEL and HH10-HEL complexes.
Because of the impact of slower docking and a faster
dissociation of the encounter complexes, the impact of the
mutations on the apparent association and dissociation rates
are exaggerated (Fig. 5, d–f and Fig. 6, j–l). The apparent
association appears to be much slower than it is because
docking has become rate limiting. This can be seen in the
FIGURE 5 (a–c) Rate constants for two-step association of (a) HH8, (b) HH10, and (c) HH26 complexes with HEL, HEL(K96A) and HEL(K97A),
calculated as described in Fig. 4. Solid black, k1; cross-hatched, k	1; gray, k2; diagonal, k	2. k1 is plotted on left axis; k	1, k2, k	2 on the right axis.
(d–f) Apparent association and dissociation rate constants of (d) HH8, (e) HH10, and (f) HH26 complexes with HEL, HEL(K96A), and HEL(K97A) were
estimated from same data as (a–c) with BIAeval 3.0.2 software (Biacore Inc.), using Langmuir model. Solid black, kon (left axis); cross-hatch, koff (right
axis). (g–i) Relative stability of the encounter complex are represented as 1/k	1 (Solid black, left axis), and relative strengths of the close range steering
effects (cross-hatch, right axis) as the product of the forward rate constants, k1k2 (Selzer and Schreiber, 2001).
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FIGURE 6 (a–i) Representative sensograms of binding of the three Fabs to HEL and mutant antigens. The rate constants (k1, k	1, k2, k	2), calculated
as described in the legend to Fig. 4 and shown in Fig. 5, were used to simulate the component curves for the encounter complex, [AB]*, and the docked
complex, AB. In each panel ——, the original binding data;    , [AB]*;   -  -, AB; and - - -, the fitted total binding. We define the point at which the
[AB]* and AB curves cross as T50, where [AB]*  AB  50% (RUtotal) (illustrated on time axis of panels a–c). Values for T50, determined from simulations
at 10-nM concentrations and a series of increasing concentrations until T50 asymptotes at a minimum value (T50m), using the rate constants determined by
global analysis (Figs. 4 and 5). T50m is a parameter that is unique and characteristic of each complex. When k1 is rate limiting (i.e., k	2  k2) T50m 
t1⁄2 of k2 (Lipschultz et al., 2000). All values are given in seconds. The values for T50m were calculated as T50mmut 	 T50mHEL for each respective
antibody. The Fab concentrations in the binding curves depicted are: (a, d, g) HH8 21 nM on all three antigens; (b) HH10 21 nM on HEL; (c) HH26 21
nM on HEL; (e) HH10 640 nM on HEL(K97A); (f) HH26 146 nM on HEL(K97A); (h) HH10 100 nM on HEL(K96A); (i) HH26 210 nM on HEL(K96A).
(j–l) simulations of (j) HH8, (k) HH10, and (l) HH26 binding to HEL (——), HEL(K96A) (- - - -), and HEL(K97A) (– . . –). All antibodies are at a
concentration of 10 nM. Insets show enlargements of HH10 and HH26 binding to HEL(K97A). Simulations are depicted to allow comparison of all
complexes at the same concentration, which could not be reliably obtained experimentally because of the widely differing affinities.
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association kinetics: an initial rapid association is followed
by a slower prolonged association phase (Fig. 6, e and f),
which results in a significantly slower net on rate using a
1-step Langmuir association model (Fig. 5, e and f). This is
particularly true for the complexes of HH10 and HH26 with
HEL(K97A). The encounter association rate constant k1 in
HH10-HEL(K97A) complex is 
5-fold lower (Fig. 5 b),
but the apparent kon is nearly 20-fold lower than the HH10-
HEL complex (Figs. 5 e and 6 k). For the HH26-
HEL(K97A) complex, the k1 is 
3-fold lower (Fig. 5 c),
whereas the apparent Kon is 60-fold lower than the HH26-
HEL complex (Figs. 5 f and 6 l). For these complexes, the
apparently large impact of the mutation on electrostatic
steering is a combination of a decreased stability of the
encounter complex and a slower conversion to the docked
state. This can be clearly seen by comparing the simulated
component curves of the respective HEL and HEL(K97A)
complexes (Fig. 6, a–f). In the HH26-HEL(K97A) complex,
docking is so severely affected that the majority of com-
plexes never dock but rapidly dissociate. The HEL(K97A)
mutation affects the transition states of the HH8 and HH10
encounter steps more than those of docking, but it affects
the transition state of HH26 docking more than that of
encounter.
The decreases in the free energy attributable to the Lys-
96Y substitution (Gmut-wild) are less than half a kcal/mol,
and insignificant compared to Lys-97Y (Figs. 4 and 5 d–f).
For the complexes with HEL(K96A), the differences of
Lys-96Y contributions in the three complexes can again be
attributed to the electrostatic nature of binding in HH26-
HEL, where lysine, being a charged epitope residue, has a
more important role in HH26-HEL binding than in HH8-
HEL and HH10-HEL (Table 5). Calculations show that the
net effect of Lys-96Y on these two complexes is destabiliz-
ing, as indicated by favorable Gm(elhydro)	w(elhydro),
which is marginally negative in cases of HH8-HEL and
HH10-HEL, showing that Lys-96Y, by itself, does not con-
tribute to the free energy of binding in these complexes. The
computational data is supported by the experimental data
(Table 5, Fig. 4). However, for both the HH10-HEL and
HH26-HEL complexes, although the net G is insignifi-
cant, G1 is 
0.5 kcal/mol, and, in HH26-HEL G2, is
nearly 	1.0 kcal/mol (Fig. 4). The K97Y mutation lowers
the activation energy for HH26 docking by 
1 kcal/mol.
The net impact of the mutation is unfavorable for both steps,
but then stabilizing to the final complex in the case of
HH26, as reflected by lower values of k	2, and a higher k2
for HH26.
Lys-97Y forms an intermolecular salt bridge in HH8-HEL
and HH26-HEL complexes. In the complexes with HEL(K97A),
Gm(elhydro)	w(elhydro) is largest for HH26, and smallest
for HH8. The decrease in the free energy of binding in all three
cases is due to the significant loss in the electrostatic contri-
bution (Table 5). The loss is largest in HH26-HEL(K97A)
and smallest in HH8-HEL(K97A), as compared to their
respective wild types. Higher sensitivity of HH26 binding to
HEL(K97A), as compared to HH8 and HH10, corresponds
to the observation that the intermolecular salt bridge,
formed between Lys-97Y and Asp-32H, is very strong in
HH26-HEL and is only marginally stabilizing in HH8-HEL.
The stabilizing impact of this electrostatic interaction is
primarily on the encounter complex, with a smaller impact
on post-encounter docking step. In the case of the HH10-
HEL complex, although the interaction between Asp-32H
and Lys-97Y did not qualify as a salt bridge, discussed
above, the contribution of Lys-97Y toward the free energy
of binding was higher than in HH8-HEL complex, appar-
ently due to the higher electrostatic nature of binding in
HH10-HEL as compared to HH8-HEL.
The large impact on the encounter step of the HH10
complex is in contrast with the effect of other Ala mutants,
which generally have a larger impact on docking than on
encounter of this antibody (Li et al., 2001; S. J. Smith-Gill,
C. A. Lipschultz, and Y. Li, unpublished data). The Lys-97Y
mutation has a slightly greater effect on docking of HH26
than on HH10.
Considering that Lys-97Y forms a stable intermolecular
salt bridge, it is intuitive that Lys-97Y will contribute more
to the free energy of complex formation than Lys-96Y.
Furthermore, in all three complexes, the side chain of Lys-
97Y is buried to a larger extent than Lys-96Y, upon complex
TABLE 6 Surface area buried upon antibody-HEL complex
formation of residues Lys-96Y and Lys-97Y
Residue Atom
Area buried upon complex formation
HH8-HEL HH10-HEL HH10Fv-HEL HH26-HEL
Lys-96Y N – – – –
C – – – –
C 0.33 0.59 0.06 0.34
O 0.37 0.55 – 0.50
C 7.12 8.65 5.78 6.55
C – – – –
C 9.46 12.16 9.16 10.51
C 0.10 – – 0.47
N	 38.87 37.23 37.98 29.24
Total buried 56.27 59.19 52.99 47.61
Lys-97Y N 0.38 0.21 0.35 0.12
C 5.44 3.66 4.68 4.39
C – – – –
O 2.11 3.56 2.95 2.34
C 5.91 0.77 7.36 4.41
C 17.12 1.13 10.45 13.15
C 10.05 21.21 12.22 9.49
C 27.46 33.39 25.93 24.88
N	 39.22 33.94 38.87 51.53
Total buried 107.70 97.86 102.81 110.32
Listing of the buried surface areas of the atoms of Lys-96Y and Lys-97Y
epitope residues upon the complex formation in HH8-HEL, HH10-HEL,
HH10Fv-HEL, and HH26-HEL.
Atoms and their positions are shown in standard codes.
Last row in each is the sum of buried areas of all the atoms in the residue.
2960 Sinha et al.
Biophysical Journal 83(6) 2946–2968
formation (Table 6). HH26-HEL complex buries the largest
surface area of Lys-97Y–N	 atom among the three com-
plexes (Table 6). The N	 atoms of Lys-96Y are buried to
similar extents in the three complexes. The more a side
chain is buried in the protein interior the higher desolvation
penalty it pays (Novotny and Sharp, 1992; Bruccoleri et al.,
1997). However, in the protein interior, due to the absence
of solvent screening, the charged side chain will have very
favorable electrostatic interactions if the protein environ-
ment permits. Strong salt bridges are usually buried in the
protein interior (Kumar and Nussinov, 1999). This further
suggests that the free energy of binding in the three com-
plexes derives larger amounts from Lys-97Y than from
Lys-96Y.
DISCUSSION
The significance of this work is that the observed variations
in the electrostatic properties of the three antibodies corre-
late with their binding properties. The high number of
short-range electrostatic interactions, very strong salt
bridges and a very strong salt-bridge pentad at the binding
site, and the largest electrostatic contributions toward bind-
ing in HH26-HEL, limit flexibility, rendering the binding
site geometry very rigid. Consequently, the epitope muta-
tions are not accommodated due to very limited conforma-
tional flexibility, or geometrical adaptability. In contrast,
the small number of electrostatic interactions, marginal
strengths of binding-site salt bridges, and small electrostatic
contributions toward binding in HH8-HEL, allow confor-
mational flexibility with less specific geometrical constrains
at the binding site. Thus this antibody accommodates
epitope mutations and is cross-reactive. HH10-HEL has
intermediate electrostatic properties, both in terms of num-
ber of short-range electrostatic interactions and electrostatic
contributions. Therefore, its binding properties relating to
conformational flexibility and specificity also fall among
the three antibodies.
The differential impacts of charge mutations on the as-
sociation steps of the complexes suggest mechanisms of
associations in the three HH-HEL complexes. Three impor-
tant conclusions can be drawn from the observations. First,
the variations in electrostatic versus hydrophobic interac-
tions correlate with, and can account for, many of the
FIGURE 7 Electrostatic and hydrophobic prop-
erties of HH-HEL complexes. The binding sites of
antibodies are shown. (a) The surface area types: i,
HH8; ii, HH10; iii, HH26. Hydrophobic, polar, and
charged residues are shown in green, cyan, and
magenta, respectively. The figure has been gener-
ated using GRASP (Nicholls et al., 1991). (b) The
components of residual potential of HH10-HEL. i,
HEL interaction potential projected onto HH10; ii,
HH10 desolvation potential. (bi) and (bii) are gen-
erated using GRASP (Nicholls et al., 1991), using
the method by Tidor and coworkers (Chong et al.,
1998; Lee and Tidor, 2001). For electrostatic
complementarity, the two components of the resid-
ual potential should be equal and opposite (Chong
et al., 1998; Lee and Tidor, 2001).
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specificity and affinity differences among the antibodies.
Second, electrostatic interactions play duo roles, directly, by
affecting specificity and affinity through complementary
polar and charged based intermolecular contacts at the bind-
ing interface, and indirectly, on structural effects, through
stabilizing the partners and their complexes, and modulating
flexibility properties of the antibodies. Third, electrostatic
effects that could be interpreted as diffusional electrostatic
steering effects on the initial association process are actually
interactions that are taking place after collision, which alter
the stabilities of the encounter complexes and the transition-
state energies of both encounter and docking steps.
The networked salt bridges, especially Glu-99H–Lys-97Y,
Arg-97H–Glu-99H, and Arg-97H–Asp-101H in HH26-HEL,
stand as very strong, even when compared with the
strengths of very stabilizing salt bridges reported in litera-
ture (Lounnas and Wade, 1997; Kumar and Nussinov,
1999). This agrees with the observation that networked salt
bridges, ion pairs, and hydrogen bonds are usually stabiliz-
ing (Kumar and Nussinov, 1999; Xiao and Honig, 1999;
Sheinerman et al., 2000). In addition, the overall electro-
static contributions to the binding energy among the wild
type and mutant complexes span a wide range. The range of
the electrostatic term spans 20 kcal/mol, compared to the
range of less than 4 kcal/mol for the hydrophobic term. The
optimization of electrostatic interactions leads to specificity
and tight binding (Sheinerman et al., 2000; Lee and Tidor,
2001). For such associations, the hydrophobicity may be
optimized to begin with, whereas enhancement in electro-
static properties leads to a tight binding (Chong et al., 1999).
Our results are consistent with these findings. The hydro-
phobic contributions are similar in all the complexes, with
little variations. The high specificity of HH26 is acquired by
the enhancement of its electrostatic properties during affin-
ity maturation.
Our results are consistent with the conclusion that the net
electrostatic component of the binding free energy is usually
unfavorable (Table 5: sum of desolvation penalty and elec-
trostatic interaction) because the unfavorable change in the
electrostatics of solvation is not fully compensated by fa-
vorable electrostatics interactions of the bound complex
(Novotny and Sharp, 1992; Bruccoleri et al., 1997). The
compensation is greatest in HH26-HEL (30.5 kcal/mol),
poorest in HH8-HEL (36.8 kcal/mol), and intermediate in
HH10-HEL (34.8 kcal/mol). The optimized compensations
between charge desolvation and favorable electrostatic in-
teractions lead to specific binding, as shown from our anal-
ysis and from previous studies (Chong et al., 1999; Lee and
Tidor, 2001). Here, it is important to emphasize the distinc-
tion between the overall electrostatic contributions and the
local electrostatic contributions through the binding-site salt
bridges. The overall electrostatic contributions mainly de-
pend on proportion and distribution of charges and influ-
ences the strengths of local interactions. The favorable
electrostatic term contributes the most in HH26-HEL, and
least in HH8-HEL (Table 5), indicating further that HH26-
HEL binding is electrostatically driven. Electrostatic inter-
actions reflect primarily the enthalpic component of asso-
ciation, and our results agree with ITC studies, which show
that, among the three complexes, HH26-HEL binding is the
most enthalpically driven (S. Mohan, unpublished).
The three antibodies exhibit differential sensitivity to
most mutations in the HEL epitope, with HH26 being the
most sensitive and HH8 the least (Lavoie et al., 1999; Li et
al., 2001). The differences in the number of charged resi-
dues versus hydrophobic residues in their respective binding
site can explain many of these specificity differences (Fig.
7). Charged residues contribute to higher specificity glo-
bally through the electrostatic contribution to the free en-
ergy of binding, and locally by forming salt bridges, and
their networks. It is expected that, for binding that is
strongly electrostatic in nature, mutating the charged resi-
dues will leave rather severe effects on antibody–antigen
associations, whereas mutating a hydrophobic residue
would be less severe. However, because the HH26-HEL
binding interface is expected to be rigid, where the binding
site of HH26 is pre-organized with a specific geometry, any
type of mutation will have a more severe affect on HH26-
HEL binding than for HH8-HEL or HH10-HEL binding.
This also agrees with the observation that the effects of
mutations are modulated through the flexible regions of
proteins (Sinha and Nussinov, 2001).
Particularly interesting is the presence of a strong in-
tramolecular salt bridge, Asp-48Y–Arg-61Y, at the HH26-
HEL binding site. This interaction is present in the uncom-
plexed HEL but is absent in HH8-HEL and HH10-HEL
complexes. In HH8-HEL and HH10-HEL, the charged
groups of the two residues, which form the salt bridge in
HH26-HEL, are not oriented optimally to form a salt bridge,
an indication of conformational adjustments upon lysozyme
binding. Preservation of an intramolecular salt bridge of
HEL upon HH26 association suggests a fine specificity of
the HH26 binding site for its epitope, where binding-site
geometry of HEL seems to be unaltered upon HH26 en-
counter and docking. This also suggests that HH26-HEL
binding is more of a “lock and key” type, whereas, in
HH8-HEL, the binding seems to be more like “induced fit”
and HH10-HEL is intermediate. This salt bridge is also
present in HH10Fv-HEL complex (Tables 2 and 3). How-
ever, the electrostatic strength of this salt bridge in
HH10Fv-HEL is nearly neutral (Table 3).
The hydrophobic component of binding is more favorable
in HH8-HEL than in HH10-HEL or HH26-HEL (Table 5).
Hydrophobic and local folding effects account for most of
the total entropy change of association (Spolar and Record,
1994). Isothermal titration calorimetry and SPR results
show that HH8-HEL binding is entropically driven. The
observed entropy would include hydrophobicity and local
folding effects. The differences in binding properties of the
three HH antibodies are mainly due to the differences in
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their electrostatic components, consistent with an earlier
report (Sharp, 1998).
Entropy–enthalpy compensation is fundamental to pro-
tein–protein associations, and is demonstrated experimen-
tally (Bhat et al., 1994; Fields et al., 1996). Most protein–
protein associations, including antibody–protein complexes,
are enthalpically driven (Chong et al., 1999), and accompa-
nied by a large unfavorable entropic change (Tamura and
Privalov, 1997). Our data show large electrostatic and hy-
drophobic contributions to the antibody–HEL associations
with larger differences among the complexes in electrostatic
component. The number of electrostatic interactions, and
their strengths, determining these features, in fact are the
predispositions of protein environments, which stem from
subtle evolutionary changes in protein sequence.
Electrostatic steering is likely a significant contributor to
the stability of the encounter complex in all three antibodies,
and, subsequently, to specific docking and determination of
affinity. This is indicated by the slight slowing of the initial
association rate constant k1 in the complexes of all three
antibodies with K97A. However, the magnitude of the
change in k1 was similar in all three antibodies. The
mutation had a much greater impact on the transition state
and stability of the encounter complexes and on docking,
properties that would reflect post-collision events. Brown-
ian dynamics simulations indicated that electrostatic steer-
ing interactions in HH10-HEL pair are weak and that the
electrostatically favored orientation gives a mismatch of

180° rotation from the orientation in the crystal structure
(Gabdoulline and Wade, 2001). This may explain why the
mutation HEL(K96A) actually has favorable changes in
some of the interaction steps. Our results with HEL(K97A)
mutation are also consistent with this conclusion, and sug-
gest that the effects of electrostatics on the apparent asso-
ciation rates, often interpreted as electrostatically enhanced
diffusion, actually reflect later, specific interactions stabi-
lizing the receptor and ligand complex, at least in these
antibody–antigen complexes.
There seem to be two general mechanisms of electrostatic
steering in protein–protein association. One, the common
view, where the electrostatic steering brings the two pro-
teins of the complex together (Schreiber and Fersht, 1996;
Gabdoulline and Wade, 2001; Lee and Tidor, 2001). The
electrostatic forces act here at pre-collision level, and en-
hance diffusional encounter (Gabdoulline and Wade, 2001).
Such examples include barnase-barstar, acetylcholinester-
ase-fasculin-2, and cytochrome c peroxidase–cytochrome c
complexes (Gabdoulline and Wade, 2001). The proteins in
such complexes would show overall electrostatic comple-
mentarity at their binding sites, and additionally can have
short-range intermolecular electrostatic interactions in
docked complexes (Chong et al., 1998; Lee and Tidor,
2001). In the other type of apparent electrostatic steering, an
alternative view, as in these three complexes, the electro-
static forces mainly act post-collision, and provide stability
and specificity through the salt bridge and their networks.
The proteins in such complexes may not show overall
electrostatic complementarity at their binding sites (Fig. 7).
This corresponds to the finding that electrostatically favor-
able orientations in HH5-HEL and HH10-HEL complexes
are found to be significantly different from their actual
bound complexes (Gabdoulline and Wade, 2001).
High-affinity antibodies have higher binding energies for
their antigens (Patten et al., 1996; Wedemayer et al., 1997;
Chong et al., 1999). Our data suggest that affinity matura-
tion of HH8 and HH26 toward HEL may be via two inde-
pendent mechanisms, where it is hydrophobically driven in
one case and electrostatically in the other. It has been
hypothesized that association rates are optimized early in
affinity maturation (Foote and Milstein, 1994). Our results
suggest that apparent increases in association rates may
actually involve optimization of post-collision process,
which also affect docking and complex stability. Thus,
similar structural mechanisms may underly optimization of
several steps of the binding process.
The continuum electrostatic model may not provide ac-
curate quantitative values, because it does not take into
account the local polarities in proteins resulting from per-
manent dipoles (Warshel et al., 1984). However, for quali-
tative comparisons, especially when experimental varifica-
tions are available, this widely used (Hendsch and Tidor,
1994; Xu et al., 1997a; Lounnas and Wade, 1997; Sinha et
al., 2001a) and experimentally supported (Waldburger et al.,
1995, 1996) method is of choice.
The calculations on theoretical models of HH8-HEL and
HH26-HEL complexes might have affected the estimated
values. However, it would not affect our conclusions for the
following reasons: 1) Theoretical models were built from
the template of more than 95% sequence identity; 2) The
conclusions are consistent with the previously reported ex-
perimental findings; 3) The conclusions from our binding
kinetics analysis and calculations correspond with each oth-
er; and 4) The conclusions are based on qualitative com-
parisons between the three complexes. The crystal struc-
tures of HH26-HEL and a chimera of Heavy-chain-8 and
Light-chain-10 complexed with HEL will soon become
available (Y. Li and R. Mariuzza, personal communication).
These finding will be further verified.
CONCLUSIONS
The electrostatics contribute both globally and locally to
protein–protein associations. Locally, electrostatic interac-
tions, both structurally and thermodynamically, play major
roles in determining specificity and affinity by limiting
conformational flexibility, as in HH26. In contrast, lack of
significant electrostatic interactions and their weak electro-
static contributions in HH8 render the binding site confor-
mationally flexible, allowing higher cross-reactivity with
mutant antigens. Intra- and intermolecular salt bridges and
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their networks play major roles in defining specificity and
affinity in HH26-HEL complex. Globally, the proportion
and distributions of charged residues determine the overall
electrostatic contributions toward binding and define the
extent of electrostatic environment in protein. The higher
number of binding-site-charged residues in HH26 results in
higher overall electrostatic contributions toward binding.
Our results also indicate that apparent “electrostatic steer-
ing,” measurable as an apparent enhancement of the initial
association rate, may actually reflect two contrasting effects.
The generally accepted phenomenon of electrostatic steering is
enhancement of diffusional encounter through what is gener-
ally believed to be a long-range interaction. However, apparent
enhancement of initial association rates may also reflect spe-
cific and local electrostatic interactions, which stabilize the
initial encounter complex through binding-site ionic interac-
tions and strong salt bridges. The apparent association rate is
accelerated because there is minimal dissociation of the en-
counter complex. Our results with site-directed mutants of two
charged epitope residues, Lys-96Y and Lys-97Y suggest that
both residues equivalently affect long-range steering, but that
only Lys-97Y mediates post-collision stabilization through the
formation of an intermolecular salt bridge and by participating
in a salt-bridge network. In contrast, Lys-96Y is not involved in
any salt-bridge formation, and, in fact, faces away from the
binding site. The measurable contributions of post-collision
interactions to the total binding energy are much higher than
long-range steering effects in both HH26-HEL and HH10-
HEL complexes. Thus, mutational evidence of apparent elec-
trostatic steering must be interpreted in light of both the bind-
ing kinetics and an analysis of the underlying electrostatic
interactions to determine the actual mechanism of action.
APPENDIX
Listing of hydrogen bonds present in CDRs and epitopes of HH8-HEL,
HH10-HEL, and HH26-HEL complexes. Hydrogen bond-forming residues
are shown. The residue name is followed by its position, which is followed
by chain identification in subscripts. Intra- and intermolecular hydrogen
bonds are marked.
Complex
H-bond
type* H-bond
Corresponding
Regions
Intra-
molecular
Inter-
molecular
HyHEL8 MC-MC Ser-35H–Ala-96H CDR1-Frame ✓
Phe-53H–Gly-55H CDR2-CDR2 ✓
Phe-53H–Asn-56H CDR2-CDR2 ✓
Asn-60H–Leu-63H CDR2-CDR2 ✓
Pro-61H–Lys-64H CDR2-CDR2 ✓
Leu-63H–Arg-66H CDR2-Frame ✓
Asn-97H–Gly-100H Frame-CDR3 ✓
Thr-5L–Arg-24L Frame-CDR1 ✓
Thr-5L–Arg-24L Frame-CDR1 ✓
Ile-29L–Asn-31L Frame-CDR1 ✓
Ile-29L–Gly-68L CDR1-Frame ✓
Ile-55L–Gly-57L CDR2-Frame ✓
Ala-9Y–Lys-13Y Epitope ✓
Ala-10Y–Lys-13Y Epitope ✓
Lys-13Y–Gly-16Y Epitope ✓
Tyr-20Y–Tyr-2Y Epitope ✓
Complex
H-bond
type* H-bond
Corresponding
Regions
Intra-
molecular
Inter-
molecular
Trp-62Y–Leu-75Y Epitope ✓
Trp-63Y–Cys-76Y Epitope ✓
Thr-89Y–Val-92Y Epitope ✓
Ala-90Y–Asn-93Y Epitope ✓
Asn-93Y–Lys-96Y Epitope ✓
Cys-94Y–Lys-97Y Epitope ✓
Lys-97Y–Ser-100Y Epitope ✓
Ile-98Y–Asp-101Y Epitope ✓
MC-SC Ile-29H–Trp-34H Frame-CDR1 ✓
Asp-32H–Tyr-33H CDR1-CDR1 ✓
Tyr-47H–Asn-60H Frame-CDR2 ✓
Glu-49H–Tyr-50H Frame-CDR2 ✓
Glu-49H–Ile-51H Frame-CDR2 ✓
Ser-52H–Arg-71H CDR2-Frame ✓
Ser-52H–Phe-53H CDR2-CDR2 ✓
Ser-52H–Asn-56H CDR2-CDR2 ✓
Asn-56H–Thr-57H CDR2-CDR2 ✓
Phe-58H–Trp-94L CDR2-Frame ✓
Tyr-59H–Trp-94L CDR2-Frame ✓
Asn-60H–Pro-61H CDR2-CDR2 ✓
Asn-60H–Ser-62H CDR2-CDR2 ✓
Ser-62H–Lys-64H CDR2-CDR2 ✓
Leu-63H–Arg-66H CDR2-Frame ✓
Asp-99H–Gly-100H CDR3-CDR3 ✓
Gly-100H–Trp-103H CDR3-Frame ✓
Val-3L–Ser-26L Frame-CDR1 ✓
Gln-27L–Ser-28L CDR1-CDR1 ✓
Gly-30L–Asn-92L CDR1-CDR3 ✓
Gly-30L–Asn-32L CDR1-CDR1 ✓
Asn-31L–Gly-16Y CDR1-Epitope ✓
Asn-31L–Arg-14Y CDR1-Epitope ✓
Thr-49L–Tyr-50L Frame-CDR2 ✓
Gln-90L–Asn-92L CDR3-CDR3 ✓
Gln-90L–Asn-93L CDR3-CDR3 ✓
Gln-90L–Asn-93L CDR3-CDR3 ✓
Gln-90L–Pro-95L CDR3-CDR3 ✓
Gln-16Y–Lys-96Y Epitope ✓
Asp-18Y–Asn-19Y Epitope ✓
Asp-18Y–Leu-25Y Epitope ✓
Asp-48Y–Gly-49Y Epitope ✓
Asp-48Y–Ser-50Y Epitope ✓
Trp-63Y–Asn-74Y Epitope ✓
Asp-87Y–Thr-89Y Epitope ✓
Asp-101Y–Asn-103Y Epitope ✓
Asp-101Y–Gly-104Y Epitope ✓
SC-SC Tyr-50H–Arg-21Y CDR2-Epitope ✓
Asn-32L–Asn-92L CDR1-CDR3 ✓
Asn-92L–Asn-93L CDR3-CDR3 ✓
HyHEL10 MC-MC Tyr-33H–Trp-98H CDR1-Frame ✓
Trp-34H–Val-51H CDR1-CDR2 ✓
Ser-35H–Ala-96H CDR1-Frame ✓
Met-48H–Asn-60H Frame-CDR2 ✓
Tyr-50H–Tyr-58H CDR2-CDR2 ✓
Ser-52H–Ser-56H CDR2-CDR2 ✓
Ser-52H–Gly-55H CDR2-CDR2 ✓
Ser-52H–Ser-56H CDR2-CDR2 ✓
Tyr-53H–Ser-56H CDR2-CDR2 ✓
Asn-60H–Leu-63H CDR2-CDR2 ✓
Pro-61H–Lys-64H CDR2-CDR2 ✓
Thr-5L–Arg-24L Frame-CDR1 ✓
Thr-5L–Arg-24L Frame-CDR1 ✓
Ile-29L–Gly-68L CDR1-Frame ✓
Gly-30L–Gly-68L CDR1-Frame ✓
Leu-33L–Tyr-50L CDR1-CDR2 ✓
Leu-33L–Tyr-50L CDR1-CDR2 ✓
His-34L–Gly-89L CDR1-CDR3 ✓
His-34L–Gln-89L CDR1-CDR3 ✓
Lys-49L–Gln-53L Frame-CDR2 ✓
Lys-49L–Ser-52L Frame-CDR2 ✓
Lys-49L–Gln-53L Frame-CDR2 ✓
Pro-95L–Thr-97L CDR3-Frame ✓
Ala-10Y–Lys-13Y Epitope ✓
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Complex
H-bond
type* H-bond
Corresponding
Regions
Intra-
molecular
Inter-
molecular
Lys-13Y–Gly-16Y Epitope ✓
Leu-17Y–Tyr-20Y Epitope ✓
Tyr-20Y–Tyr-23Y Epitope ✓
Tyr-20Y–Tyr-23Y Epitope ✓
Trp-63Y–Leu-75Y Epitope ✓
Trp-63Y–Cys-76Y Epitope ✓
Thr-89Y–Val-92Y Epitope ✓
Asn-93Y–Lys-96Y Epitope ✓
Cys-94Y–Lys-97Y Epitope ✓
Lys-97Y–Ser-100Y Epitope ✓
Ile-98Y–Asp-101Y Epitope ✓
MC-SC Ile-29H–Trp-34H Frame-CDR1 ✓
Thr-30H–Ser-31H Frame-CDR1 ✓
Asp-32H–Trp-34H CDR1-CDR1 ✓
Asp-32H–Tyr-33H CDR1-CDR1 ✓
Tyr-47H–Asn-60H Frame-CDR2 ✓
Tyr-59H–Trp-94L CDR2-CDR3 ✓
Tyr-59H–Ile-69H CDR2-Frame ✓
Asn-60H–Pro-61H CDR2-CDR2 ✓
Asn-60H–Ser-62H CDR2-CDR2 ✓
Asn-97H–Tyr-102H Frame-CDR3 ✓
Gly-100H–Trp-103H CDR3-Frame ✓
Val-3L–Ser-26L Frame-CDR1 ✓
Ser-26L–Gln-27L CDR1-CDR1 ✓
Gly-30L–Asn-32L CDR1-CDR1 ✓
Gly-30L–Asn-31L CDR1-CDR1 ✓
Asn-31L–Asn-32L CDR1-CDR1 ✓
Asn-31L–Gly-16Y CDR1-Epitope ✓
Asn-32L–Gly-16Y CDR1-Epitope ✓
Gln-89L–Gln-90L CDR3-CDR3 ✓
Gln-90L–Ser-93L CDR3-CDR3 ✓
Gln-90L–Pro-95L CDR3-CDR3 ✓
Asn-92L–Asn-19Y CDR3-Epitope ✓
His-15Y–Lys-96Y Epitope ✓
Asp-18Y–Asn-19Y Epitope ✓
Asp-18Y–Asn-19Y Epitope ✓
Asp-48Y–Gly-49Y Epitope ✓
Asp-48Y–Ser-50Y Epitope ✓
Trp-63Y–Asn-74Y Epitope ✓
Asp-87Y–Thr-89Y Epitope ✓
Asp-101Y–Gly-102Y Epitope ✓
Asp-101Y–Asn-103Y Epitope ✓
SC-SC Tyr-50H–Arg-21Y CDR2-Epitope ✓
Tyr-50H–Arg-21Y CDR2-Epitope ✓
Asp-99H–His-34L CDR2-Frame ✓
Asn-32L–Asn-92L CDR1-CDR3 ✓
Gln-53L–Asn-93Y CDR2-Epitope ✓
HyHEL26 MC-MC Trp-34H–Ile-51H CDR1-CDR2 ✓
Trp-34H–Ile-51H CDR1-CDR2 ✓
Ser-35H–Ala-96H CDR1-Frame ✓
Met-48H–Asn-60H Frame-CDR2 ✓
Ser-52H–Ser-56H CDR2-CDR2 ✓
Ser-52H–Gly-55H CDR2-CDR2 ✓
Ser-52H–Ser-56H CDR2-CDR2 ✓
Asn-60H–Leu-63H CDR2-CDR2 ✓
Pro-61H–Lys-64H CDR2-CDR2 ✓
Leu-63H–Arg-66H CDR2-Frame ✓
Arg-97H–Met-100H Frame-CDR3 ✓
Thr-5L–Arg-24L Frame-CDR1 ✓
Ile-29L–Gly-68L CDR1-Frame ✓
Ile-29L–Gly-68L CDR1-Frame ✓
Asn-32L–Ser-91L CDR1-CDR3 ✓
Leu-33L–Tyr-50L CDR1-CDR2 ✓
Leu-33L–Tyr-50L CDR1-CDR2 ✓
Leu-47L–Ile-55L Frame-CDR2 ✓
Lys-49L–Ala-51L Frame-CDR2 ✓
Lys-49L–Gln-53L Frame-CDR2 ✓
Asn-92L–Arg-21Y CDR3-Epitope ✓
Ala-10Y–Lys-13Y Epitope ✓
Lys-13Y–Gly-16Y Epitope ✓
Leu-17Y–Tyr-20Y Epitope ✓
Tyr-20Y–Tyr-23Y Epitope ✓
Tyr-20Y–Tyr-23Y Epitope ✓
Complex
H-bond
type* H-bond
Corresponding
Regions
Intra-
molecular
Inter-
molecular
Trp-62Y–Leu-75Y Epitope ✓
Trp-63Y–Leu-75Y Epitope ✓
Thr-89Y–Val-92Y Epitope ✓
Ala-90Y–Asn-93Y Epitope ✓
Asn-93Y–Lys-96Y Epitope ✓
Asn-93Y–Lys-97Y Epitope ✓
Cys-94Y–Lys-97Y Epitope ✓
Lys-97Y–Ser-100Y Epitope ✓
Ile-98Y–Asp-101Y Epitope ✓
MC-SC Val-2H–Tyr-102H Frame-CDR3 ✓
Ile-29H–Trp-34H Frame-CDR1 ✓
Asp-32H–Trp-34H CDR1-CDR1 ✓
Asp-32H–Arg-71H CDR1-Frame ✓
Ile-51H–Arg-71H CDR2-Frame ✓
Tyr-59H–Trp-94L CDR2-CDR3 ✓
Tyr-59H–Ile-69H CDR2-Frame ✓
Asn-60H–Pro-61H CDR2-CDR2 ✓
Asn-60H–Ser-62H CDR2-CDR2 ✓
Met-100H–Trp-103H CDR3-Frame ✓
Asp-101H–Tyr-102H CDR3-Frame ✓
Gln-27L–Ser-28L CDR1-CDR1 ✓
Ser-30L–Asn-32L CDR1-CDR1 ✓
Ser-30L–Asn-31L CDR1-CDR1 ✓
Asn-31L–Arg-14Y CDR1-Epitope ✓
Asn-32L–Gly-16Y CDR1-Epitope ✓
Ala-51L–Gln-53L CDR2-CDR2 ✓
Ser-52L–Gln-53L CDR2-CDR2 ✓
Ser-52L–Gln-53L CDR2-CDR2 ✓
Ser-54L–Ile-55L CDR2-CDR2 ✓
Ser-56L–Gly-57L CDR2-Frame ✓
Gln-89L–Tyr-96L CDR3-CDR3 ✓
Gln-90L–Asn-92L CDR3-CDR3 ✓
Gln-90L–Ser-93L CDR3-CDR3 ✓
Gln-90L–Ser-93L CDR3-CDR3 ✓
Gln-90L–Pro-95L CDR3-CDR3 ✓
Asn-92L–Arg-21Y CDR3-Epitope ✓
Asn-92L–Asn-19Y CDR3-Epitope ✓
Ser-93L–Trp-94L CDR3-CDR3 ✓
Asn-18Y–Asn-19Y Epitope ✓
Asp-48Y–Arg-61Y Epitope ✓
Asp-48Y–Gly-49Y Epitope ✓
Trp-63Y–Asn-74Y Epitope ✓
Asp-87Y–Thr-89Y Epitope ✓
Thr-89Y–Asn-93Y Epitope ✓
Asp-101Y–Gly-102Y Epitope ✓
Asp-101Y–Asn-103Y Epitope ✓
SC-SC Tyr-50H–Arg-21Y CDR2-Epitope ✓
Tyr-50H–Arg-21Y CDR2-Epitope ✓
Arg-97H–Glu-99H Frame-CDR3 ✓
His-15Y–Thr-89Y Epitope ✓
Asp-18Y–Asn-19Y Epitope ✓
Arg-21Y–Ser-100Y Epitope ✓
*H-bond, hydrogen-bond; MC–MC, main chain–main chain; MC–SC, main chain–
side chain; SC–SC, side chain–side chain; CDR, complementarity determining region.
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